Clinical Trial Services (CRO) · Health Data & Interoperability
IQVIA revenue, results and funding
IQVIA filed revenue of $16.3B for 2025.
Data updated Nov 22, 2026 · Back to the company report
$16.3BRevenue, 2025
$1.4BNet income, 2025
93,000Employees, 2025
IQVNew York Stock Exchange
Results by year
| Year | Revenue | Net income | Total assets | Employees | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_DIVIDENDS | LANG_CR_S_M_BUYBACKS | LANG_CR_S_M_CAPEX | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT | LANG_CR_S_M_ACQUISITIONS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $16.3B | $1.4B | $29.9B | 93,000 | – | $252M | – | $1.2B | $603M | $247M | – | $2.2B | $2B | $13.9B | $1.7B |
| 2024 | $15.4B | $1.4B | $26.9B | 88,000 | $295M | $301M | – | $1.4B | $602M | $206M | – | $2.2B | $1.7B | $12.8B | $735M |
| 2023 | $15B | $1.4B | $26.7B | 87,000 | $340M | $101M | – | $992M | $649M | $217M | – | $2B | $1.4B | $13B | $876M |
| 2022 | $14.4B | $1.1B | $25.3B | 86,000 | $255M | $260M | – | $1.2B | $674M | $194M | – | $1.8B | $1.2B | $12.6B | $1.3B |
| 2021 | $13.9B | $966M | $24.7B | 79,000 | $222M | $163M | – | $406M | $640M | $170M | – | $1.4B | $1.4B | $12B | $1.5B |
| 2020 | $11.4B | $279M | $24.6B | 70,000 | $209M | $72M | – | $447M | $616M | $95M | – | $731M | $1.8B | $12.4B | $177M |
| 2019 | $11.1B | $191M | $23.3B | 67,000 | $215M | $116M | – | $949M | $582M | $146M | – | $777M | $837M | $11.5B | $588M |
| 2018 | $10.4B | $259M | $22.5B | 58,000 | $211M | $59M | – | $1.4B | $459M | $113M | – | $741M | $891M | $10.9B | $309M |
| 2017 | $9.7B | $1.3B | $22.9B | 55,000 | $195M | −$992M | – | $2.6B | $369M | $106M | – | $665M | $959M | $10.1B | $854M |
| 2016 | $6.9B | $72M | $21.2B | 50,000 | $106M | $325M | – | $1.1B | $164M | $106M | – | $576M | $1.2B | $7.1B | −$1.9B |
| 2015 | $5.7B | $387M | $3.9B | 36,100 | $121M | $159M | – | $515M | $78M | $38M | $3.3M | $646M | $977M | $2.4B | −$32M |
| 2014 | $5.5B | $357M | $3.3B | 32,600 | $139M | $149M | – | $415M | $83M | $30M | $5.8M | $590M | $867M | $2.3B | $92M |
| 2013 | $5.1B | $226.6M | $3.1B | 28,200 | $71M | $96M | – | $6.4M | $88.3M | $22.8M | $5M | $462.3M | $777M | $2B | $145M |
| 2012 | $4.9B | $177.5M | $2.5B | – | $104M | $93.4M | $567.9M | $13.4M | $71.3M | $25.9M | $10.4M | $396.4M | $567.7M | $2.4B | $43.2M |
| 2011 | $4.3B | $241.8M | $2.3B | – | $63.4M | $15.1M | $288.3M | $14.3M | $75.7M | $14.1M | $10M | $345.3M | $516.3M | – | $227.1M |
Sources: SEC
How to cite
IQVIA, Financials. Alion, Nov 22, 2026. https://alion.io/company/iqvia/financials
